Printable Sweetener Charts
Three charts, drawn from the same sourced records as the answer cards on our sweetener guides. Each is laid out to print on one sheet of A4 or US Letter, in black on white. They are free to print and need no sign-up. Where our records hold no sourced figure the cell shows a dash; we do not estimate one. These charts describe sweeteners. They do not tell you what to eat.
Disclosure: the operator of this site sells erythritol-based products, so we have a commercial interest in some of the sweeteners this tool covers. Every figure links to its source so you can check it. See our terms for how we handle this.
Zero Sugar AI zerosugar.ai/tools/printable-charts/
Chart 1. Sweetness and conversion
Figures checked between 29 Aug 2026 and 27 Oct 2026
How sweet each sweetener is against sugar, the weight that matches 100 g of sugar for sweetness, and whether it adds bulk.
Xylitol: Life-threatening to dogs
MECHANISM: in humans xylitol does not stimulate insulin release; in dogs it is absorbed rapidly and triggers a potent insulin release, causing profound hypoglycaemia within 10 to 60 MINUTES. Signs: vomiting, then decreased activity, weakness, staggering, incoordination, collapse, seizures. Serious effects can be delayed 12 to 24 hours, so a well-looking dog still needs a vet. Also called BIRCH SUGAR or WOOD SUGAR on labels. Present in gum, mints, sugar-free candy, baked goods, cough syrup, chewable vitamins, mouthwash, toothpaste, some peanut and nut butters, and "skinny" ice cream. Ferrets are also affected; cats appear largely spared. Never use human toothpaste on a pet.
US Food and Drug Administration, Center for Veterinary Medicine regulatory checked 30 Aug 2026Aspartame: Mandatory label warning for people with phenylketonuria (PKU)
Aspartame is hydrolysed on digestion into phenylalanine, aspartic acid and methanol. People with phenylketonuria (PKU) — a rare inherited disorder, screened for in newborns via a routine heel-prick test — cannot metabolise phenylalanine normally, and it accumulates to harmful levels. 21 CFR 172.804(d)(2) makes the warning mandatory: every aspartame-containing product must state "PHENYLKETONURICS: CONTAINS PHENYLALANINE", required to appear "prominently and conspicuously" in bold type on a clear contrasting background. EFSA's 2013 re-evaluation is explicit that the ADI itself does not apply to this population: PKU patients "require strict adherence to a diet low in phenylalanine" regardless of the ADI figure. Separately, EFSA modelled even PKU HETEROZYGOTES (genetic carriers, not affected) at intakes up to the ADI and found no risk to a developing fetus from phenylalanine exposure via aspartame — a safety margin that does not extend to someone who actually has PKU.
Cornell Legal Information Institute (eCFR text) regulatory checked 23 Oct 2026A sugar substitute cannot treat a low blood glucose
Low blood glucose is below 70 mg/dL. The ADA's stated rule is 15 grams of FAST-ACTING carbohydrate, then recheck after 15 minutes — none of the substitutes on this site qualify, because not raising blood glucose is the entire point of them. Severe hypoglycaemia is an emergency needing help from others; if someone is unconscious and glucagon is unavailable or nobody knows how to use it, call 911. Your own care plan takes priority over anything written here.
American Diabetes Association clinical guidance checked 31 Aug 2026| Sweetener | Sweetness | Same sweetness as 100 g of sugar | Bulk contribution |
|---|---|---|---|
| Erythritol | 60–80% of sugar[1]NoteSpecification band. Measured potency is concentration-dependent: 0.72 / 0.75 / 0.84 against 5 / 10 / 15% w/v sucrose (Wee 2018); 0.50-0.78 across 3-20% (Fujimaru 2012). | 125–167 g[1] | Bulking[1]NoteUsed as a bulk sweetener, but a 1:1 weight swap under-sweetens because it delivers only 60-80% of sucrose sweetness. |
| Allulose | 70% of sugar[2]NoteCommonly cited as approximately 70% of sucrose. Convergent across Xie 2024, Han 2018 and the comments FDA received on the 2014 proposed rule — but this is a repeated figure, not a specification band or a sensory measurement, and no concentration dependence has been characterised the way it has for erythritol. | 143 g[2] | Bulking[2]NoteUsed at sugar-like weights, but above 20% sucrose replacement in sponge cake hardness and chewiness rose significantly, and specific volume fell from 3.36 to 2.96 cm3/g at 50% replacement. A 1:1 swap also under-sweetens at ~70% relative sweetness. |
| Monk Fruit | 100–250× sweeter than sugar[3]NoteA MULTIPLE, not a fraction — see the header warning. CORRECTED 2026-08-30 from an earlier 100-400 band: FDA gives 100-250 for the EXTRACT ("SGFE, depending on the mogroside content, is reported to be 100 to 250 times sweeter than sugar"), while the ~250 figure in the literature describes PURE mogroside V. Those are not in conflict once you separate extract from active compound, and the extract figure is the one that matters commercially. Potency tracks mogroside V content, which varies 2%-95% between grades. | 0.4–1 g[3] | None[4]NoteHigh-intensity sweetener used at milligram levels; contributes no volume, structure, browning or mouthfeel. Any product that fills a measuring cup is doing so with something else. This is why tabletop "monk fruit" is usually a blend. |
| Stevia | 200–400× sweeter than sugar[3]NoteA MULTIPLE, not a fraction. FDA's figure for steviol glycosides as a class. Individual glycosides differ: stevioside is the least potent and rebaudioside A among the most, so a reformulation that swaps Reb A for Reb M changes potency without changing the word "stevia" on the label. | 0.25–0.5 g[3] | None[3]NoteHigh-intensity; contributes no volume, structure, browning or mouthfeel. Anything cup-for-cup is mostly carrier. |
| Sugar (sucrose) | 100% of sugar[5]NoteBy definition. Sucrose IS the reference against which every other figure in this file is expressed. | 100 g[5] | No sourced figure |
| Xylitol (dog warning above) | 98–112% of sugar† declared interest, given under the table[6]NoteA FRACTION, not a multiple — xylitol is a BULK sweetener like erythritol, not a high-intensity one; see the monk-fruit record's header for why that distinction is load-bearing for this field name. Concentration-dependent, from the SAME 16-sweetener psychophysical dose-response study already cited narratively for erythritol's sweetness (Wee, Tan & Forde 2018) but not previously given its own source entry here: matching concentrations required to equal 5/10/15% w/v sucrose were 5.1/9.9/13.3% w/v xylitol, giving relative potency 0.98/1.01/1.12 — essentially equisweet to sucrose across the tested range, trending slightly SWEETER than sucrose at the higher concentration rather than under-sweet like erythritol. This is a single peer-reviewed measurement, not a regulatory specification band (no JECFA/EFSA specification document found stating a sweetness figure for xylitol on this pass) — treat the range as what one controlled sensory panel measured, not as an official spec. | 89–102 g† declared interest, given under the table[6] | No sourced figure |
| Sucralose | 600× sweeter than sugar[3]NoteA MULTIPLE, not a fraction. FDA: "about 600 times sweeter than table sugar." | 0.17 g[3] | None[3]NoteHigh-intensity; used in milligrams. Anything cup-for-cup is mostly carrier. |
| Aspartame (PKU warning above) | 200× sweeter than sugar[3]NoteA MULTIPLE, not a fraction. FDA: aspartame "is about 200 times sweeter" than table sugar. | 0.5 g[3] | None[3]NoteHigh-intensity; used in milligrams. Anything cup-for-cup is mostly carrier. |
| Saccharin | 200–700× sweeter than sugar[3]NoteA MULTIPLE, not a fraction. GAP CLOSED 2026-09-01: the range is now confirmed against FDA's own primary page, which states it verbatim — "It is 200 to 700 times sweeter than table sugar (sucrose)." The earlier pass on this record could not reach FDA.gov (HTTP 404 on every URL tried) and recorded the range on secondary attribution while explicitly asking a future session to open an FDA primary source; that access failure was transient, and the same URLs resolved normally later the same day. The wide band is REAL and should not be collapsed to a single number — FDA states 200-700 as the range itself. Note separately that FDA's own "Safe Levels of Sweeteners" chart assumes 400x when computing packet counts, which is a calculation assumption inside that document, not a competing claim about potency. | 0.14–0.5 g[3] | None[7]NoteHigh-intensity; used in milligrams. Anything cup-for-cup is mostly carrier. Saccharin is also known for a bitter/metallic aftertaste at higher concentrations, which is why it is very often blended with another sweetener (historically cyclamate outside the US, now more often sucralose or aspartame) rather than used alone — not independently sourced to a primary document this pass, recorded as common-knowledge context only. |
| Acesulfame Potassium | 200× sweeter than sugar[3]NoteA MULTIPLE, not a fraction. FDA: acesulfame potassium "is about 200 times sweeter than table sugar" — same figure as aspartame, which is why the two are so commonly blended (see heat_stability: Ace-K's stability complements aspartame's instability, and blending lets formulators use less of each). | 0.5 g[3] | None[3]NoteHigh-intensity; used in milligrams. Anything cup-for-cup is mostly carrier. |
| Neotame | 7000–13000× sweeter than sugar[3]NoteA MULTIPLE, not a fraction — and the largest range in this file after advantame. FDA: "approximately 7,000 to 13,000 times sweeter than table sugar." The band is genuinely wide because perceived potency of high-intensity sweeteners is concentration-dependent; do not collapse it to a single number. | 7.7–14 mg[3] | None[3]NoteHigh-intensity, used in milligrams. Contributes no volume, structure, browning or mouthfeel. |
| Advantame | 20000× sweeter than sugar[3]NoteA MULTIPLE, not a fraction — and by a distance the highest in this file. FDA: "approximately 20,000 times sweeter than table sugar (sucrose)." For scale: roughly 100x sweeter than aspartame and 33x sweeter than sucralose. FDA's own "Safe Levels of Sweeteners" chart puts the practical consequence starkly — a 60 kg person would need 4,920 sweetener packets in a day to reach the ADI, against 75 for aspartame and 23 for sucralose. | 5 mg[3] | None[3]NoteHigh-intensity; contributes no volume, structure, browning or mouthfeel. At 20,000x, the amount in a finished product is often measured in micrograms per serving. |
| Tagatose | 90% of sugar[8]NoteMeasured, not a spec: in a 34-panellist sensory study across 3-20% sucrose-equivalent solutions, tagatose ran at about 0.90 of sucrose AT EVERY CONCENTRATION — its sweetness curve had almost exactly sucrose's slope, unlike erythritol, which the same study put at 0.50-0.78. So a 1:1 swap by weight comes close to matching sweetness, which no polyol in this file does except xylitol. The UK FSA quotes "75-92%" with no primary source; the "92%" figure common in trade press was not found in any primary document. Abstract read; full text not opened. | 111 g[8] | Bulking[9]NoteUsed at sugar-like weights; at about 0.9 sucrose sweetness, close to a 1:1 swap. JECFA lists its functions as sweetener, texturizer, stabilizer, humectant and formulation aid. |
| Maltitol | 89–95% of sugar† declared interest, given under the table[6]NoteA FRACTION, and the closest of the common polyols to sugar. Same 16-sweetener psychophysical panel already cited for erythritol and xylitol (Wee, Tan & Forde 2018): 5.6/11.2/15.8% w/v maltitol matched 5/10/15% sucrose, potency 0.93/0.89/0.95. The authors single out maltitol, with xylitol, as "most similar to sucrose in terms of dose-response behaviour, growth rate and potency". One sensory panel, not a specification; no JECFA or EFSA document gives a sweetness figure. Ignore the "2.7 kcal/g" and "GI 36" in the same paper's background table — they are not its measurements. | 105–112 g† declared interest, given under the table[6] | Bulking† declared interest, given under the table[10]Note"Maltitol presents characteristics close to sucrose, with similar molecular weight (disaccharide), melting point and hygroscopicity" — with near-sugar sweetness, the reason it is the default polyol in sugar-free chocolate. |
| Sorbitol | 72–83% of sugar† declared interest, given under the table[6]NoteA FRACTION. The same 16-sweetener panel used for erythritol, xylitol and maltitol (Wee, Tan & Forde 2018): 6.3/13.7/17.9% w/v sorbitol matched 5/10/15% sucrose, potency 0.80/0.72/0.83. The authors group it with the weaker sweeteners: "Dextrose, erythritol, sorbitol and mannitol all had lower sweetness intensities than sucrose across the concentration range tested". Handbooks quote lower figures (about 0.5-0.6) without a traceable measurement; this record uses the measured one. One sensory panel, not a specification. | 120–139 g† declared interest, given under the table[6] | Bulking[11]NoteJECFA's functional uses: "Sweetener, humectant, sequestrant, texturizer, stabilizer, bulking agent". FDA's good-manufacturing maximums run from 12% of most foods to 99% of hard candy and cough drops (21 CFR 184.1835(d)). |
| Inulin (chicory root fibre) | Oligofructose about 30-35% of sugar; native inulin less, with no measured figure found† declared interest, given under the table[12]NoteFrom a review, not a sensory measurement: oligofructose and short-chain FOS have "a sweetness value of 30%–35% that of sucrose" (Jackson, Wijeyesekera & Rastall 2023; no conflicts declared). The often-quoted "about 10%" for native inulin traces to an industry-authored 1999 review that could not be opened, so it is not used. In practice inulin is a bulking fibre paired with another sweetener, not a sugar substitute on its own. | No sourced figure | Bulking† declared interest, given under the table[12]NoteShort chains give bulk and mild sweetness; long-chain inulin "can form fat‐mimicking gels" at concentrations above 10-20%, which is why it also appears as a fat replacer. FDA's first GRAS notice for chicory inulin (GRN 118) was for use "as a bulking agent". |
| Yacon syrup | No sourced figure | No sourced figure | No sourced figure |
No sourced figure in our records. A dash is not a zero, and we do not estimate one.
"Same sweetness as 100 g of sugar" is worked out from the sweetness column: 100 g divided by each end of the stored range, with no midpoint chosen. It is by weight only; our records hold no sourced cup or spoon measures.
Equal sweetness is not equal bulk, browning or texture. The bulk column says whether a sweetener adds bulk at all.
Rows that read "× sweeter than sugar" describe the pure compound or extract. Retail packets and cup-for-cup blends are mostly carrier; our records hold no figures for them, and this chart cannot convert them.
Open "Note" under a figure for the qualifications that go with it. The number in square brackets is its source, listed under the chart.
Declared interest (Xylitol (sweetness); Maltitol (sweetness); Sorbitol (sweetness)): "C.F. has received reimbursements for speaking at conferences sponsored by companies selling food ingredients and nutritional products, and currently serves on the scientific advisory council of a commercial ingredient manufacturer." Funded by a Singapore public research grant.
Declared interest (Maltitol (bulk contribution)): Funded by the Pays de la Loire region and the EU Horizon 2020 SWEET project; "The authors declare no conflict of interest."
Declared interest (Inulin (chicory root fibre) (sweetness); Inulin (chicory root fibre) (bulk contribution)): "CONFLICT OF INTEREST None to declare."
Print or save as PDF: chart 1 of 3, Sweetness and conversion
Sources for chart 1
The warnings above the chart carry their own source lines.
- Re-evaluation of erythritol (E 968) as a food additive. EFSA Panel on Food Additives and Flavourings, EFSA Journal 21(12):e8430. regulatory checked 29 Aug 2026
- Low-calorie d-allulose as a sucrose alternative modulates the physicochemical properties and volatile profile of sponge cake. Xie X, Yu L, Lin Q, Huang D; Journal of Food Science 89(10):6296-6307. peer reviewed checked 30 Aug 2026
- Aspartame and Other Sweeteners in Food. US Food and Drug Administration. regulatory checked 30 Aug 2026, 31 Aug 2026, 1 Sep 2026 and 23 Oct 2026
- GRAS Notice No. GRN 000706 — Siraitia grosvenorii fruit extract (Hunan Nutramax), FDA response letter. US FDA, Office of Food Additive Safety. regulatory checked 30 Aug 2026
- 21 CFR 101.9 — Nutrition labeling of food. Cornell Legal Information Institute (eCFR text). regulatory checked 30 Aug 2026
- A Comparison of Psychophysical Dose-Response Behaviour across 16 Sweeteners. Wee MSM, Tan VWK, Forde CG; Nutrients 10(11):1632. peer reviewed checked 31 Aug 2026 and 27 Oct 2026Declared interest: "C.F. has received reimbursements for speaking at conferences sponsored by companies selling food ingredients and nutritional products, and currently serves on the scientific advisory council of a commercial ingredient manufacturer." Funded by a Singapore public research grant.
- 21 CFR 180.37 — Saccharin, ammonium saccharin, calcium saccharin, and sodium saccharin. Cornell Legal Information Institute (eCFR text). regulatory checked 1 Sep 2026
- Sensory characteristics and relative sweetness of tagatose and other sweeteners. Fujimaru T, Park JH, Lim J; Journal of Food Science 77(9):S323-S328. peer reviewed checked 27 Oct 2026
- D-Tagatose — JECFA evaluation summary (2000-2004). Joint FAO/WHO Expert Committee on Food Additives (INCHEM mirror of the JECFA database). regulatory checked 27 Oct 2026
- Impact of Maltitol and Sorbitol on Technological and Sensory Attributes of Biscuits. Roze M, Crucean D, Diler G, et al.; Foods 10(11):2545. peer reviewed checked 27 Oct 2026Declared interest: Funded by the Pays de la Loire region and the EU Horizon 2020 SWEET project; "The authors declare no conflict of interest."
- Sorbitol (INS 420(i)) and sorbitol syrup (INS 420(ii)) — JECFA specification monographs. Food and Agriculture Organization of the United Nations. regulatory checked 27 Oct 2026
- Inulin-type fructans and short-chain fructooligosaccharides — their role within the food industry as fat and sugar replacers and texture modifiers — what needs to be considered!. Jackson PPJ, Wijeyesekera A, Rastall RA; Food Science & Nutrition 11(1):17-38. peer reviewed checked 27 Oct 2026Declared interest: "CONFLICT OF INTEREST None to declare."
Sources, the date each was opened, and the qualifications that go with each figure are listed under this chart at zerosugar.ai/tools/printable-charts/. Figures change: check the page before relying on an old printout.
Disclosure: the operator of this site sells erythritol-based products, so we have a commercial interest in some of the sweeteners this tool covers. Every figure links to its source so you can check it. See our terms for how we handle this.
Educational information, not medical or dietary advice. This tool does not know your situation and does not tell you what to eat. If you are managing diabetes, are pregnant, take medication, or have a condition affected by what you eat, talk to a clinician or a registered dietitian before acting on anything it shows.
Zero Sugar AI zerosugar.ai/tools/printable-charts/
Chart 2. Blood glucose and calories
Figures checked between 29 Aug 2026 and 27 Oct 2026
What each record holds on blood glucose and on calories, for every sweetener we keep a sourced record on.
Xylitol: Life-threatening to dogs
MECHANISM: in humans xylitol does not stimulate insulin release; in dogs it is absorbed rapidly and triggers a potent insulin release, causing profound hypoglycaemia within 10 to 60 MINUTES. Signs: vomiting, then decreased activity, weakness, staggering, incoordination, collapse, seizures. Serious effects can be delayed 12 to 24 hours, so a well-looking dog still needs a vet. Also called BIRCH SUGAR or WOOD SUGAR on labels. Present in gum, mints, sugar-free candy, baked goods, cough syrup, chewable vitamins, mouthwash, toothpaste, some peanut and nut butters, and "skinny" ice cream. Ferrets are also affected; cats appear largely spared. Never use human toothpaste on a pet.
US Food and Drug Administration, Center for Veterinary Medicine regulatory checked 30 Aug 2026Aspartame: Mandatory label warning for people with phenylketonuria (PKU)
Aspartame is hydrolysed on digestion into phenylalanine, aspartic acid and methanol. People with phenylketonuria (PKU) — a rare inherited disorder, screened for in newborns via a routine heel-prick test — cannot metabolise phenylalanine normally, and it accumulates to harmful levels. 21 CFR 172.804(d)(2) makes the warning mandatory: every aspartame-containing product must state "PHENYLKETONURICS: CONTAINS PHENYLALANINE", required to appear "prominently and conspicuously" in bold type on a clear contrasting background. EFSA's 2013 re-evaluation is explicit that the ADI itself does not apply to this population: PKU patients "require strict adherence to a diet low in phenylalanine" regardless of the ADI figure. Separately, EFSA modelled even PKU HETEROZYGOTES (genetic carriers, not affected) at intakes up to the ADI and found no risk to a developing fetus from phenylalanine exposure via aspartame — a safety margin that does not extend to someone who actually has PKU.
Cornell Legal Information Institute (eCFR text) regulatory checked 23 Oct 2026A sugar substitute cannot treat a low blood glucose
Low blood glucose is below 70 mg/dL. The ADA's stated rule is 15 grams of FAST-ACTING carbohydrate, then recheck after 15 minutes — none of the substitutes on this site qualify, because not raising blood glucose is the entire point of them. Severe hypoglycaemia is an emergency needing help from others; if someone is unconscious and glucagon is unavailable or nobody knows how to use it, call 911. Your own care plan takes priority over anything written here.
American Diabetes Association clinical guidance checked 31 Aug 2026| Sweetener | Blood glucose | Calories |
|---|---|---|
| Erythritol | 0 (glucose = 100)† declared interest, given under the table[1]NoteMean 0, SD 17 across 4 studies (glucose = 100). Insulinaemic index 2. The SD is large relative to the mean: this is "no detectable effect", not a precise zero. | 0 kcal per gram[2] |
| Allulose | Negligible; no established GI value — reduces POSTPRANDIAL glucose and insulin (moderate certainty), but no significant effect on HbA1c, fasting glucose/insulin, lipids, uric acid or body composition[3]NoteUPDATED 2026-08-31 with the field's current best synthesis, previously flagged in this backlog as bot-blocked — it is Open Access and loads cleanly in a real browser; only automated fetchers (WebFetch, server curl) were gated, the same JS bot-check pattern already on file for EUR-Lex and the ADA Standards of Care. Osborn, DuPuis, Liu, Della Corte & Della Corte 2026 (AJCN 123(6):101314) is a PROSPERO-registered (CRD42024567433) systematic review and meta-analysis of 20 controlled human intervention trials (12 allulose, 8 tagatose; 1,033 participants total), searched through 30 April 2025 — broader than either single study previously cited here. ALLULOSE ARM: significantly reduced postprandial glucose (incremental AUC SMD -0.66, 95% CI -0.92 to -0.39, moderate certainty) and postprandial insulin (SMD -1.27, 95% CI -2.14 to -0.40, moderate certainty) — but NO significant pooled effect on HbA1c, fasting glucose, fasting insulin, blood lipids, uric acid, or body composition (very low to moderate certainty across those outcomes). Read the postprandial finding and the null findings together: the acute glucose/insulin-blunting effect this record has documented since Tani 2023 holds up under a larger, more rigorous synthesis, but it does not extend to weight, fasting markers or long-term glycaemic control on the evidence gathered so far — allulose blunts a spike, it has not been shown to improve the numbers that matter for longer-run metabolic health. No third-party funding; the review's only disclosed conflict (SL) is unrelated consulting/editorial work with no rare-sugar-industry tie, a materially cleaner disclosure than tani2023's Kagawa University rare-sugar-group authorship (still flagged on that source below). Tani 2023 (145 participants/group, healthy adults, mechanism-establishing) and Ayesh 2024 (126 people with type 2 diabetes, first T2D-specific signal) remain cited in full below as the specific studies this broader 2026 synthesis draws on and updates, not as duplicated or superseded claims. | 0.4 kcal per gram[4]NoteENFORCEMENT DISCRETION, not a rule. FDA states that under 21 CFR 101.9(c)(1)(B) "a caloric value of 4 kcal/g must currently be used for allulose because it is a carbohydrate", and that it merely intends not to enforce that pending rulemaking. Two citizen petitions asked for 0.4 and 0.2; FDA chose the higher figure because it "would not underestimate the caloric contribution". |
| Monk Fruit | No meaningful glucose or insulin spike in healthy adults, acutely[5]NoteTey et al. 2017, the only published human RCT of monk fruit sweetener itself (as opposed to its regulatory toxicology). 30 healthy men, randomised crossover, four 65 g-sucrose-equivalent preloads (aspartame, monk fruit, stevia, sucrose). Monk fruit, stevia and aspartame all produced significantly lower postprandial glucose and insulin than sucrose, with no meaningful spike above baseline for any of the three. THE MORE INTERESTING FINDING: ad libitum lunch intake after the non-nutritive-sweetener preloads was significantly HIGHER than after sucrose — compensatory eating largely offset the calories saved at the preload, leaving total daily energy intake unchanged across all four arms. Read as evidence about the preload only, not as evidence the sweetener itself changes appetite regulation days or weeks out — one meal, one measurement. | Negligible at use levels[6]NoteDeliberately not stated as "0 kcal/g". No authority has assigned monk fruit extract a caloric factor the way FDA assigned erythritol 0 and allulose 0.4. What is documented is the exposure: mean SGFE intake up to 1.6 mg/kg bw/day, 90th percentile 4.2 mg/kg bw/day in healthy adults. |
| Stevia | Low-certainty evidence of reduced fasting glucose, strongest under 120 days of use[7]NoteZare et al. 2024, meta-analysis of 26 RCTs, 1,439 participants (PROSPERO CRD42023414411). Stevia supplementation significantly reduced fasting glucose, with the effect most consistent in trials shorter than 120 days and in participants with higher BMI, diabetes or hypertension. NO significant effect on insulin concentration or HbA1c — the fasting-glucose finding does not generalise to those two measures. Authors rate the overall certainty of evidence LOW and call for more RCTs at higher stevia doses. Read alongside health_claim_status below: a real, specific, but modest and short-duration signal — not evidence of durable metabolic benefit. | No sourced figure |
| Sugar (sucrose) | 65 (glucose = 100)† declared interest, given under the table[1]NoteGlucose = 100. Sucrose is a glucose-fructose disaccharide, so only about half of it is glucose on hydrolysis — which is why its GI sits below pure glucose rather than at it. | 4 kcal per gram[2]NoteThe general factor for total carbohydrate under 21 CFR 101.9(c)(1)(i)(B). This is the number every "reduced calorie" claim on this site is implicitly measured against. |
| Xylitol (dog warning above) | No sourced figure | 2.4 kcal per gram[2]NoteThe HIGHEST of any polyol FDA assigns a factor to, and 60% of sugar's 4 kcal/g — nowhere near erythritol's 0. The full FDA table: erythritol 0, mannitol 1.6, isomalt 2.0, lactitol 2.0, maltitol 2.1, xylitol 2.4, sorbitol 2.6, hydrogenated starch hydrolysates 3.0. Anyone treating "sugar alcohol" as a single low-calorie category is wrong by a factor of infinity at one end of that list. |
| Sucralose | No sourced figure | No sourced figure |
| Aspartame (PKU warning above) | No sourced figure | Contains calories; negligible at use levels[8]NoteFDA: aspartame "contains calories, but consumers will likely use less than they would of table sugar." It is metabolised as two ordinary amino acids (phenylalanine, aspartic acid) plus methanol, so unlike saccharin or Ace-K it does yield energy; it is negligible in practice only because of the tiny mass used per serving at about 200x sweetness. CHANGED 2026-10-27 from calories_per_g_us = 4.0: that field is for a per-gram factor an authority assigned, and the cited FDA page gives no per-gram figure. The commonly quoted 4 kcal/g (e.g. EUFIC) was not found in an FDA, EFSA or JECFA document this pass. |
| Saccharin | No sourced figure | 0 kcal per gram[9]NoteCONFIRMED 2026-09-01 against FDA's own page, which states it flatly: saccharin "contains no calories." CFR 180.37 independently frames saccharin as a "non-nutritive sweetening agent," not merely low-calorie — unlike aspartame (metabolised as amino acids, so it does yield energy, negligible at use levels) or allulose (metabolised only partially, FDA-assigned 0.4 kcal/g by enforcement discretion), saccharin passes through without being metabolised as an energy source at all. No FDA nutrition-labelling regulation assigning it a specific non-zero per-gram factor was found this pass (it does not appear in 21 CFR 101.9's polyol caloric-factor table, which does not cover high-intensity sweeteners in any case). |
| Acesulfame Potassium | No sourced figure | 0 kcal per gram[10]NoteUnlike aspartame (metabolised as amino acids, so it yields some energy), Ace-K is not metabolised by the human body at all — JECFA's absorption/distribution data show it passes through largely unchanged. Genuinely calorie-free, not merely negligible-at-use-levels. |
| Neotame | No sourced figure | 0 kcal per gram[8]NoteEffectively zero at use levels. Neotame is used in milligram quantities at 7,000-13,000x sweetness, so any caloric contribution is immeasurable in practice. No FDA per-gram caloric factor was located for it this pass (it does not appear in 21 CFR 101.9's polyol table, which covers sugar alcohols only and would not apply). Distinct from aspartame, which is metabolised as amino acids and so does yield energy, merely negligible in practice. |
| Advantame | No sourced figure | 0 kcal per gram[8]NoteEffectively zero at use levels — the most extreme case in this file, since advantame is used at roughly 1/20,000th the mass of sugar for equal sweetness. No FDA per-gram caloric factor was located this pass; 21 CFR 101.9's table covers sugar alcohols only and does not apply. |
| Tagatose | No rise from tagatose alone; lowers the postprandial response to other carbohydrate; small pooled HbA1c reduction (-0.25 points), leaning on industry-run trials[3]NoteOsborn et al. 2026 (AJCN; PROSPERO CRD42024567433; the same review session 14 used for allulose): across 8 tagatose trials, postprandial glucose SMD -1.03 (-1.36 to -0.71) and insulin SMD -1.05 (-1.61 to -0.49), both moderate certainty; HbA1c mean difference -0.25 (-0.44 to -0.06), moderate certainty — the one long-run marker where tagatose beat allulose, which showed no HbA1c effect in the same review; fasting insulin lower at very low certainty; "No other significant pooled effects". Abstract only — the tagatose trial list, and therefore how much weight the next study carries in the pool, was not seen. READ THE LARGEST TRIAL WITH ITS CONFLICT: Ensor 2015 (phase 3, 494 randomised, people with type 2 diabetes not on glucose-lowering drugs, 15 g three times a day for 10 months) was "supported in part by the Biospherics subsidiary of Spherix Incorporated", the company developing tagatose as a diabetes drug, and its corresponding author "was president of Spherix at the time the clinical data were collected". Much of its placebo-adjusted effect is HbA1c RISING in the placebo arm (US subgroup at month 10: tagatose -0.07, placebo +0.37). The only independent long-term study found, a 12-month uncontrolled pilot (Donner 2010, n=8 completers), saw HbA1c fall from 10.6% to 9.6%, NOT significant (p=0.08), with GI side effects in 10 of 12 recruited. FDA's 2025 letter "acknowledges the different effect D-tagatose has on glycemic response in certain studies" — a regulator acknowledging studies, not an efficacy finding. | 1.5 kcal per gram[11]NoteENFORCEMENT DISCRETION, not a rule — the same footing as allulose's 0.4. FDA's letter of 21 November 2025 "recognizes D-tagatose's caloric value of 1.5 calories per gram" and says FDA will not object to its use when declaring calories. The figure is older than the letter: FDA said in 2022 it would not object to 1.5 kcal/g, and the GRN 977 notice traces it to a 1999 FDA labelling letter that this pass did not locate. THE EU DISAGREES BY A FACTOR OF TWO: EFSA concluded in November 2016 that the energy value for labelling is 3 kcal/g (as reported by the UK Food Standards Agency, fsa_rp1652; EFSA's own opinion was blocked). Whether the EU wrote that into law was not checked. Quote the authority with the number. |
| Maltitol | 35 (glucose = 100)† declared interest, given under the table[1]NotePooled from 9 studies, SD 9 (Livesey 2003, Table 5; the text gives SD 7 — the table is cited). Insulinaemic index 27. SYRUPS RUN HIGHER: high-maltitol syrup 48, intermediate 53, regular 52, high-polymer 36 (glucose = 100; sucrose 65 in the same table). IN CHOCOLATE the glucose response falls (GI 29) but the INSULIN response rises to 82 — against 76 for sugar chocolate; in Livesey's words "maltitol-based chocolate has an II comparable with sucrose-based chocolate", unlike isomalt or erythritol chocolate. A pooled review figure, not a modern ISO-style GI test; none newer was found. DECLARED INTEREST: "This analysis and review was commissioned by the European Polyol Association." | 2.1 kcal per gram[12]NoteFDA's factor for crystalline maltitol, 21 CFR 101.9(c)(1)(i)(F) — about half of sugar's 4. The EU uses one figure for all polyols except erythritol: 2.4 kcal/g (Reg 1169/2011 Annex XIV). MALTITOL SYRUP is not in FDA's table, and the regulation does not say whether a syrup takes maltitol's 2.1 or the 3.0 for hydrogenated starch hydrolysates; this record does not guess. Livesey's review puts maltitol's absorption, as glucose and sorbitol after hydrolysis, at roughly a third to a half of the dose. |
| Sorbitol | 9 (glucose = 100)† declared interest, given under the table[1]NotePooled from 10 studies, SD 4; insulinaemic index 11 (SD 6, 6 studies). Glucose = 100; sucrose 65 in the same review (Livesey 2003, Table 5 and abstract). The individual studies used 20-50 g doses, in healthy people and in type 1 and type 2 diabetes. A pooled review figure, not a modern ISO-style GI test. DECLARED INTEREST: the review was commissioned by the European Polyol Association. | 2.6 kcal per gram[12]NoteFDA's factor, 21 CFR 101.9(c)(1)(i)(F): the highest of any single polyol in the table (hydrogenated starch hydrolysates, at 3.0, are a mixture), above xylitol 2.4 and maltitol 2.1. The EU uses 2.4 kcal/g for all polyols except erythritol (Reg 1169/2011 Annex XIV). |
| Inulin (chicory root fibre) | Lowers the post-meal rise when it replaces sugar; long-term HbA1c benefit unproven outside one country's trials† declared interest, given under the table[13]NoteACUTE: two double-blind crossover trials (n=40-42) found that yogurt with 20% less sugar and fruit jelly with 30% less sugar, made up with oligofructose or inulin, lowered the glucose response, and "The reduction of postprandial glycaemia was positively correlated to the proportion of sugars replaced" (Lightowler 2018; two authors at BENEO, an inulin maker). That is a REPLACEMENT effect, which is all the EU's authorised claim says. LONG-TERM: Wang 2019 (33 trials) reports fasting glucose -0.60 mmol/L and HbA1c -0.58% in prediabetes and type 2 diabetes. Its own subgroup table shows where that comes from: across all trials, Iranian trials gave HbA1c -0.75% (-1.00 to -0.50), trials from all other countries -0.08% (-0.27 to 0.11, not significant), and fasting glucose -0.10 (-0.22 to 0.02, not significant); the eight industry-sponsored trials showed nothing (-0.01). No glycaemic index for inulin or oligofructose was found. | 2 kcal per gram[12]NoteNo inulin-specific factor: 21 CFR 101.9(c)(1)(i)(C) says "A general factor of 2 calories per gram for soluble non-digestible carbohydrates shall be used." The EU's factor for fibre is also 2 kcal/g (Reg 1169/2011 Annex XIV). The energy comes from bacterial fermentation in the colon, not from glucose. Free sugars carried by the ingredient count at 4 kcal/g. |
| Yacon syrup | Added to breakfast, it lowered the early glucose peak in one trial; two weeks of daily use did not change fasting glucose† declared interest, given under the table[14]NoteACUTE: 40 women, crossover, breakfast plus 40 g yacon syrup (14 g FOS) or plus placebo: "Glucose and insulin concentrations were lowered after yacon syrup intake as compared to placebo at following times: 30 min for glucose and 15, 30 and 45 min for insulin" (Adriano 2019). That is syrup ADDED to a meal, not syrup in place of sugar. TWO WEEKS: 40 g a day against placebo, 30 completers: "Yacon syrup did not affect blood lipid, glucose or metabolic endotoxemia" (Dionísio 2020). Both trials come from the Embrapa group that makes the syrup they tested. No glycaemic index measured to a standard method was found. | About 1.6-2.7 kcal per gram, depending on the batch† declared interest, given under the table[15]NoteCIP's two syrup batches measured 164 and 265 kcal per 100 g, "el contenido de calorías puede variar fácilmente entre 164 y 265 kcal", and the difference tracks the FOS content. On a US label the FOS fraction would take 2 kcal/g (21 CFR 101.9(c)(1)(i)(C)) and the free sugars 4. A reduced-calorie syrup, not a calorie-free one. |
No sweetener here is established to improve long-term health ADA Standards of Care 2026, Section 5: "NNS do not appear to have a significant effect on glycemic management," and evidence on weight is mixed — some reviews find modest weight-loss benefit, others an association with weight gain, likely reflecting reverse causation and confounding; added to an eating plan without energy restriction, NNS show no weight benefit. Substituting can reduce sugar and calories. That is a different claim from improving an outcome, and only the first is supported. CORROBORATED 2026-08-31 at much larger scale: Jeong et al.'s umbrella review (29 meta-analyses, 24 observational studies plus 6 RCTs, 50M+ participants, 135 associations examined) found observational studies link higher sweetener intake to INCREASED risk of weight gain, metabolic syndrome, type 2 diabetes and hypertension, while RCTs show only modest weight-loss benefit versus sugar specifically. The two study designs are not measuring the same comparison — see the general-health page for why — but neither supports a durable, independent long-term health benefit, which is the ADA position this guardrail already states.American Diabetes Association Professional Practice Committee for Diabetes; Diabetes… clinical guidance checked 31 Aug 2026
No sourced figure in our records. A dash is not a zero, and we do not estimate one.
Blood glucose: a number followed by "(glucose = 100)" is a glycemic index. A sentence is our record's description of the measured response where it holds no index.
Calories: figures are kcal per gram, from the field our records keep for the US label. Not every figure is a labelling rule: some rest on enforcement discretion, on a regulator's statement, or on an expert committee's evaluation. The note with each figure on the page says which. Words are the record's own description where it holds no per-gram figure. EU label factors can differ, and our records do not hold them as figures.
Open "Note" under a figure for the qualifications that go with it. The number in square brackets is its source, listed under the chart.
Declared interest (Erythritol (blood glucose); Sugar (sucrose) (blood glucose); Maltitol (blood glucose); Sorbitol (blood glucose)): "This analysis and review was commissioned by the European Polyol Association, to whom the author is grateful for support." The author ran a nutrition consultancy (Independent Nutrition Logic). It is also the source of every polyol GI in this file (see erythritol's livesey2003).
Declared interest (Inulin (chicory root fibre) (blood glucose)): Chinese public funding; "The authors declare that they have no competing interests."
Declared interest (Yacon syrup (blood glucose)): Brazilian public funding (CAPES); the syrup was made by Embrapa, the authors' institution.
Declared interest (Yacon syrup (calories)): CIP develops and promotes yacon syrup processing; the manual also makes untested benefit claims (weight, caries), which this record does not use.
Print or save as PDF: chart 2 of 3, Blood glucose and calories
Sources for chart 2
The warnings above the chart carry their own source lines.
- Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Livesey G, Nutrition Research Reviews 16:163-191. peer reviewed checked 29 Aug 2026, 30 Aug 2026 and 27 Oct 2026Declared interest: "This analysis and review was commissioned by the European Polyol Association, to whom the author is grateful for support." The author ran a nutrition consultancy (Independent Nutrition Logic). It is also the source of every polyol GI in this file (see erythritol's livesey2003).
- 21 CFR 101.9 — Nutrition labeling of food. Electronic Code of Federal Regulations. regulatory checked 29 Aug 2026 and 30 Aug 2026
- Glycemic and cardiometabolic effects of rare sugars allulose and tagatose: a systematic review and meta-analysis of controlled human intervention trials. Osborn L, DuPuis K, Liu S, Della Corte D, Della Corte KA; American Journal of Clinical Nutrition 123(6):101314. peer reviewed checked 31 Aug 2026 and 27 Oct 2026
- The Declaration of Allulose and Calories from Allulose on Nutrition and Supplement Facts Labels: Guidance for Industry. US FDA, Center for Food Safety and Applied Nutrition. regulatory checked 30 Aug 2026
- Effects of aspartame-, monk fruit-, stevia- and sucrose-sweetened beverages on postprandial glucose, insulin and energy intake. Tey SL, Salleh NB, Henry J, Forde CG; International Journal of Obesity 41(3):450-457. peer reviewed checked 31 Aug 2026
- GRAS Notice No. GRN 000706 — Siraitia grosvenorii fruit extract (Hunan Nutramax), FDA response letter. US FDA, Office of Food Additive Safety. regulatory checked 30 Aug 2026
- Effect of stevia on blood glucose and HbA1C: A meta-analysis. Zare M, Zeinalabedini M, Ebrahimpour-Koujan S, Bellissimo N, Azadbakht L; Diabetes & Metabolic Syndrome: Clinical Research & Reviews 18(7):103092. peer reviewed checked 31 Aug 2026
- Aspartame and Other Sweeteners in Food. US Food and Drug Administration. regulatory checked 1 Sep 2026 and 27 Oct 2026
- 21 CFR 180.37 — Saccharin, ammonium saccharin, calcium saccharin, and sodium saccharin. Cornell Legal Information Institute (eCFR text). regulatory checked 1 Sep 2026
- Acesulfame potassium (WHO Food Additives Series 28). Joint FAO/WHO Expert Committee on Food Additives (JECFA), 37th meeting, Geneva, 5-14 June 1990. regulatory checked 23 Oct 2026
- Letter to Bonumose, Inc. on the labeling of D-tagatose (enforcement discretion). US FDA, Human Foods Program — signed Kyle Diamantas, Deputy Commissioner for Human Foods. regulatory checked 27 Oct 2026
- 21 CFR 101.9 — Nutrition labeling of food. Electronic Code of Federal Regulations. regulatory checked 27 Oct 2026
- Inulin-type fructans supplementation improves glycemic control for the prediabetes and type 2 diabetes populations: results from a GRADE-assessed systematic review and dose–response meta-analysis of 33 randomized controlled trials. Wang L, Yang H, Huang H, et al.; Journal of Translational Medicine 17:410. peer reviewed checked 27 Oct 2026Declared interest: Chinese public funding; "The authors declare that they have no competing interests."
- Yacon syrup reduces postprandial glycemic response to breakfast: A randomized, crossover, double-blind clinical trial. Adriano LS, Dionísio AP, Abreu FAP, Carioca AAF, et al.; Food Research International 126:108682. peer reviewed checked 27 Oct 2026Declared interest: Brazilian public funding (CAPES); the syrup was made by Embrapa, the authors' institution.
- Jarabe de yacón: Principios y procesamiento. Manrique I, Párraga A, Hermann M; Centro Internacional de la Papa (CIP), Lima. Serie Conservación y uso de la biodiversidad de raíces y tubérculos andinos No. 8A. reference checked 27 Oct 2026Declared interest: CIP develops and promotes yacon syrup processing; the manual also makes untested benefit claims (weight, caries), which this record does not use.
Sources, the date each was opened, and the qualifications that go with each figure are listed under this chart at zerosugar.ai/tools/printable-charts/. Figures change: check the page before relying on an old printout.
Disclosure: the operator of this site sells erythritol-based products, so we have a commercial interest in some of the sweeteners this tool covers. Every figure links to its source so you can check it. See our terms for how we handle this.
Educational information, not medical or dietary advice. This tool does not know your situation and does not tell you what to eat. If you are managing diabetes, are pregnant, take medication, or have a condition affected by what you eat, talk to a clinician or a registered dietitian before acting on anything it shows.
Zero Sugar AI zerosugar.ai/tools/printable-charts/
Chart 3. Digestive tolerance and laxative labels
Figures checked between 29 Aug 2026 and 3 Nov 2026
What our records hold on digestive tolerance, and when a label must carry a laxative statement. These are two different things.
Xylitol: Life-threatening to dogs
MECHANISM: in humans xylitol does not stimulate insulin release; in dogs it is absorbed rapidly and triggers a potent insulin release, causing profound hypoglycaemia within 10 to 60 MINUTES. Signs: vomiting, then decreased activity, weakness, staggering, incoordination, collapse, seizures. Serious effects can be delayed 12 to 24 hours, so a well-looking dog still needs a vet. Also called BIRCH SUGAR or WOOD SUGAR on labels. Present in gum, mints, sugar-free candy, baked goods, cough syrup, chewable vitamins, mouthwash, toothpaste, some peanut and nut butters, and "skinny" ice cream. Ferrets are also affected; cats appear largely spared. Never use human toothpaste on a pet.
US Food and Drug Administration, Center for Veterinary Medicine regulatory checked 30 Aug 2026A sugar substitute cannot treat a low blood glucose
Low blood glucose is below 70 mg/dL. The ADA's stated rule is 15 grams of FAST-ACTING carbohydrate, then recheck after 15 minutes — none of the substitutes on this site qualify, because not raising blood glucose is the entire point of them. Severe hypoglycaemia is an emergency needing help from others; if someone is unconscious and glucagon is unavailable or nobody knows how to use it, call 911. Your own care plan takes priority over anything written here.
American Diabetes Association clinical guidance checked 31 Aug 2026| Sweetener | Digestive tolerance | Laxative warning label |
|---|---|---|
| Erythritol | Single sitting: 0.5–1 g/kg in one sittingPer day: EU limit 0.5 g/kg per day[1]NoteEFSA pooled NOAELs for diarrhoea from 10 human studies: range 0.51-1.0 g/kg bw, median 0.75. EFSA adopted the lower bound, 0.5 g/kg bw/day, as its first numerical ADI for erythritol (Dec 2023) and found children's 95th-percentile intake already exceeds it. | EU and UK: required above 10% added polyols, and on every table-top sweetener containing polyols. US: none found[2]NoteEU, Reg (EU) 1169/2011 Annex III point 2.4: "Foods containing more than 10 % added polyols authorised pursuant to Regulation (EC) No 1333/2008" must carry "excessive consumption may produce laxative effects". Separately, with no threshold, Reg (EC) 1333/2008 Art 23(3)(a): "The labelling of a table-top sweetener containing polyols ... shall bear the following warnings: (a) polyols: 'excessive consumption may induce laxative effects'". Erythritol is one of those polyols: Reg (EU) 1129/2011 lists "E 968 Erythritol" in Group IV, Polyols, with sorbitol and maltitol (eu1129e). The rule applies to it exactly as to maltitol, sorbitol and xylitol; the 10% counts all added polyols in the food together. No exemption was found in the texts opened. Cargill applied for one, and EFSA (2023) concluded "the available data do not support the applicant's proposal for the exemption of erythritol" and that the warning "remains appropriate". Great Britain keeps both provisions unchanged in retained law. S.I. 2025/361 reg 23(1) keeps the E 968 authorisation in effect. US: none found in the texts opened, which were the eCFR search (erythritol appears only in 21 CFR 101.9 and 101.80) and FDA's letters for GRN 76, 208, 382, 401, 789 and 1296. The CFR laxative statements are ingredient-specific: sorbitol 50 g/day (184.1835(e)), mannitol 20 g/day (180.25(e)), polydextrose over 15 g per serving (172.841(e)). They apply to an erythritol blend containing those ingredients. |
| Allulose | Single sitting: 0.4 g/kg in one sitting · severe symptoms at 0.5 g/kgPer day: 0.9 g/kg per day[3]NoteHan 2018, two non-randomised dose-escalation experiments (n=30 and n=19), Korean adults aged 21-30 with BMI 18.5-23. Severe diarrhoea appeared at 0.5 g/kg single dose. The authors explicitly warn that "considerably more symptoms may appear in individuals who are old, obese, or with certain metabolic and GI diseases" and flag the small sample and a possibly inadequate one-week washout. Not a regulatory ADI — no authority has set one. | None found in EU, UK or US rules; the EU/UK 10% polyol rule does not reach it[2]NoteEU/UK: the only general laxative statement, Reg (EU) 1169/2011 Annex III point 2.4 (same wording in the GB retained text), covers "Foods containing more than 10 % added polyols authorised pursuant to Regulation (EC) No 1333/2008". It does not reach allulose. Annex I point 8 puts "all monosaccharides" under 'sugars' "but excludes polyols". Allulose is a monosaccharide, not a polyol, and is not an additive authorised under 1333/2008. There is also no Union-list entry that could carry a tagatose-style condition: allulose is absent from the adopted Reg (EU) 2017/2470 annex, EFSA could not establish its safety in 2025 (see eu_status), and a legislation.gov.uk search for "allulose" returns no results. Not opened: the current consolidated EU list (EUR-Lex bot-check) and the FSA's GB domestic list (retained 2015/2283 Art 3B, since S.I. 2025/361). US: eCFR has no section naming allulose or psicose. Its laxative statements are tied to single ingredients (172.841 polydextrose, 180.25 mannitol, 184.1835 sorbitol). FDA's 2020 allulose labelling guidance requires none. The GRN 693 letter and every later 'no questions' letter through GRN 1342 (19 Oct 2026) contain no laxative statement. This is an absence in the texts opened, not a ruling that none is needed. The lack of a mandatory warning says nothing about tolerance, which is lower than erythritol's (see tolerance: 0.4 g/kg in a single dose). |
| Xylitol (dog warning above) | No sourced figure | EU and UK: required above 10% added polyols, and on every table-top sweetener containing polyols. US: none found[2]NoteEU, Reg (EU) 1169/2011 Annex III point 2.4: "Foods containing more than 10 % added polyols authorised pursuant to Regulation (EC) No 1333/2008" must carry "excessive consumption may produce laxative effects". Xylitol (E 967, Group IV polyols) is one of those polyols, so the rule applies to it exactly as to erythritol, maltitol and sorbitol; the 10% counts all added polyols in the food together. Separately, with no threshold, Reg (EC) 1333/2008 Art 23(3)(a): "The labelling of a table-top sweetener containing polyols ... shall bear the following warnings: (a) polyols: 'excessive consumption may induce laxative effects'" (eu1333a23x). UK: the revised GB text of point 2.4 is word for word the same, the GB text of Art 23(3) is unchanged, and although SI 2025/361 omitted Annex II of 1333/2008 from 1 April 2025, its reg 23(1) keeps those authorisations in effect "as if it were an authorisation made under" the amended Regulation (uksi2025_361x). US: 21 CFR 172.395 says only that xylitol "may be safely used in foods for special dietary uses, provided the amount used is not greater than that required to produce its intended effect" and has no labelling paragraph. An eCFR search of Title 21 for "laxative" finds food label statements only for sorbitol (184.1835), mannitol (180.25) and polydextrose (172.841), none for xylitol. So none found in the texts opened; any such line on a US xylitol product is the maker's own choice. FDA GRAS letters were not opened. |
| Tagatose | GI effects from about 30 g in one sitting; EU/UK labels warn above 15 g per serving[4]NoteJECFA (2004): "ingestion of 30g or more of D-tagatose on a single occasion may cause gastrointestinal effects in humans" — a caution about use levels, NOT a recommended maximum, though the GRN 977 dossier paraphrases it as one. In a screening study of 73 healthy young men given about 30 g, nausea ran at 15.1% and diarrhoea at 31.5%, and flatulence did not settle over 15 days of 30 g a day (Buemann 1999); 20 g in chocolate did not significantly increase watery stools (Lee & Storey 1999); 75 g at once caused diarrhoea, nausea and/or flatulence in every subject (Donner 1999). In the EU and UK "a tolerable single dose of no more than 15 g D-tagatose per serving was agreed", and the novel-food authorisation requires "excessive consumption may produce laxative effects" on any product above 15 g per serving and on drinks above 1% tagatose. We found no US label requirement in the texts opened. FDA's own exposure estimate in GRN 977 puts the 90th-percentile US eater at 39.8 g a day — above the 30 g single-sitting caution if eaten at once. Most tolerance studies are abstract-only here and sit in a 1999 journal supplement of tagatose safety studies; sponsorship was not visible. | EU/UK: required above 15 g per serving, and in drinks above 1%. US: none found[5]NoteEU wording, from the Union-list entry: "The labelling of any product where the level of D-Tagatose exceeds 15 g per serving and all beverages containing greater than 1 % D-Tagatose (as consumed) shall bear a statement 'excessive consumption may produce laxative effects'." This is a novel-food condition; the general EU rule for foods over 10% added polyols does not apply, because tagatose is a sugar, not a polyol. UK: the FSA/FSS assessment RP1652 (fsa_rp1652) says the 15 g per serving condition "was agreed for the EU and UK authorisation"; the GB domestic novel-food list itself was not opened. US: none found in the texts opened. Tagatose has no 21 CFR section: an eCFR search of Title 21 for "tagatose" finds only 101.80 (the dental-caries claim), and the eCFR "laxative" food label statements are only 172.841, 180.25 and 184.1835. FDA's GRN 977 letter (grn977_letter) contains no laxative statement; its labelling section covers only claims. The GRN 78 and 352 letters were not opened. |
| Maltitol | About 30 g in chocolate with no significant symptoms; diarrhoea from 20-45 g when taken in water† declared interest, given under the table[6]NoteIN CHOCOLATE (young adults, eaten as breakfast): 30 g caused no significant symptoms and 40 g only mild wind and gut noise, with no laxative effect at either dose ("Maltitol did not have any laxative effect when ingested at either 30 g (P = 0.32) or 40 g (P = 0.13) per day", Koutsou 1996, n=59; Storey 1998, n=20). IN WATER on an empty stomach (Japanese women, mean 52 kg): 22 of 27 got osmotic diarrhoea at doses between 20 and 45 g, and "No subject had osmotic diarrhea after the ingestion of 15 g of maltitol" (Oku 2008; maltitol donated by a manufacturer). SPREAD THROUGH THE DAY and raised until symptoms (n=12): mean threshold 93 g a day on maltitol against 113 g on sucrose, and no adaptation after 9 days of regular intake (Ruskone-Fourmestraux 2003). So the popular "maltitol chocolate gives everyone diarrhoea" overstates the controlled trials; a bolus on an empty stomach is a different matter. The chocolate studies are abstract-only here and their funding was not visible. | EU and UK: required above 10% added polyols, and on every table-top sweetener containing polyols. US: none found[2]NoteEU, Reg (EU) 1169/2011 Annex III point 2.4: "Foods containing more than 10 % added polyols authorised pursuant to Regulation (EC) No 1333/2008" must carry "excessive consumption may produce laxative effects". Maltitol (E 965, Group IV polyols) is one of those polyols, exactly as erythritol, xylitol and sorbitol are; the 10% counts all added polyols in the food together. Separately, with no threshold, Reg (EC) 1333/2008 Art 23(3)(a): "The labelling of a table-top sweetener containing polyols ... shall bear the following warnings: (a) polyols: 'excessive consumption may induce laxative effects'" (eu1333a23m). UK: the current GB text of point 2.4 is word for word the same, and the GB text of Art 23(3) is unchanged (uk1169m). US: none found in the texts opened, which were the eCFR search of Title 21 for "maltitol" (21 CFR 101.9 and 101.80 only) and the eCFR search for "laxative" (food label statements only in 172.841 polydextrose, 180.25 mannitol and 184.1835 sorbitol). FDA's 1993-94 letters in the closed GRAS docket were not opened. Any such line on a US maltitol product is the maker's own choice. |
| Sorbitol | Gas and bloating from about 10 g in one dose, severe symptoms at 20 g; malabsorption detectable from 5 g[7]NoteHyams 1983 (n=7, breath hydrogen): "ingestion of as little as 5 g sorbitol was associated with a significant increase in breath hydrogen concentration. Most subjects experienced mild gastrointestinal distress (gas, bloating) after 10 g and severe symptoms (cramps, diarrhea) after 20 g." Jain 1985 (n=42, 10 g): clinical intolerance in 43% of white and 55% of non-white subjects; severe intolerance 32% against 4%. Yao 2014 (Monash, double-blind, 10 g): only 33% of healthy subjects and 40% of people with IBS absorbed it completely, and symptoms rose significantly in the IBS group only, "independent of malabsorption". MEDICINES: the EMA keeps an adult laxative-warning threshold of 10 g and proposes 140 mg/kg a day ("equivalent of 10 g/70 kg"), noting children can be more sensitive. All three trials are single doses in solution on an empty stomach; nothing opened measured sorbitol eaten with food through the day. | US: required where daily intake may reach 50 g. EU and UK: required above 10% added polyols, and on every table-top sweetener containing polyols[8]NoteUS, 21 CFR 184.1835(e): "The label and labeling of food whose reasonably foreseeable consumption may result in a daily ingestion of 50 grams of sorbitol shall bear the statement: 'Excess consumption may have a laxative effect.'" EU, Reg (EU) 1169/2011 Annex III point 2.4: foods with "more than 10 % added polyols" must carry "excessive consumption may produce laxative effects". Sorbitol (E 420, Group IV polyols) is one of those polyols, exactly as erythritol, xylitol and maltitol are; the 10% counts all added polyols in the food together. Separately, with no threshold, Reg (EC) 1333/2008 Art 23(3)(a): "The labelling of a table-top sweetener containing polyols ... shall bear the following warnings: (a) polyols: 'excessive consumption may induce laxative effects'" (eu1333a23s). UK: the current GB text of point 2.4 is word for word the same, and the GB text of Art 23(3) is unchanged (uk1169s). The two triggers are not equivalent (a daily intake against a concentration), and the US one is 2.5 to 5 times the 10-20 g at which the trials found symptoms. |
| Inulin (chicory root fibre) | Inulin: up to about 5 g a day for no more than mild flatulence. Oligofructose: 10 g in one dose caused substantial symptoms† declared interest, given under the table[9]NoteREVIEW (Mysonhimer & Holscher 2022, 17 inulin and 17 FOS trials in adults): "Low doses of 0.75–5 g/d inulin led to only mild flatulence, medium doses of 7.5–20 g/d led to mild and moderate symptoms, and higher doses (≥22 g/d) resulted in study dropouts"; for oligofructose or FOS, "a reasonable recommendation to avoid intolerance symptoms is 7.8 g/d". Publication fees were paid by an industry-pooled committee, and one author has grants from food companies and honoraria from Beneo. TRIAL (Bonnema 2010, n=26, Cargill-funded): "Doses up to 10 g/day of native inulin and up to 5 g/day of oligofructose were well-tolerated in healthy, young adults"; "The 10-g dose of oligofructose substantially increased GI symptoms". Shorter chains are harder on the gut. The EU bowel-function claim needs 12 g a day, above the review's 5 g comfort level. | None found in EU, UK or US rules[2]NoteThe EU laxative statement applies to foods with "more than 10 % added polyols" (Reg 1169/2011 Annex III 2.4); inulin is not a polyol. The current UK text of point 2.4 is word for word the same (uk1169i). US: none found in the texts opened: no 21 CFR section affirms inulin as GRAS, and the eCFR "laxative" food statements are only 172.841, 180.25 and 184.1835. An absence in the texts opened, not a ruling that none is needed. |
| Yacon syrup | About 10 g FOS a day tolerated; about 20 g FOS a day caused intolerable symptoms. How much syrup that is depends on its FOS content† declared interest, given under the table[10]NoteGenta 2009, 120 days: 0.14 g FOS/kg a day "went through the whole experimental period with no difficulties", while 20 g FOS/70 kg a day caused diarrhoea, severe distension, flatulence and nausea: "The subjects considered the flatulence severe and unacceptable and no adaptation in symptoms occurred over time". At Genta's 41% FOS, 10 g FOS is about 24 g of syrup; at 22% FOS (the syrup used in most later trials) it is about 45 g. Shorter trials: 20 g syrup a day (6.4 g FOS) was "well tolerated" (Geyer 2008, n=16, with a CIP co-author). | None found: not a polyol, so the EU/UK 10% polyol rule misses it. US: none found[2]NoteEU and UK: Reg (EU) 1169/2011 Annex III point 2.4 (adopted text, and the current UK retained text, which is the same) requires "excessive consumption may produce laxative effects" only for "Foods containing more than 10 % added polyols authorised pursuant to Regulation (EC) No 1333/2008". Yacon syrup's FOS are fructans, not polyols, and no other Annex III entry covers FOS or fibre. A yacon product blended with more than 10% added polyols (erythritol, maltitol, sorbitol, xylitol or any other Group IV polyol) does need the statement, because of the polyol. US: an eCFR search of Title 21 for "laxative effect" finds food statements only for sorbitol (184.1835(e)), mannitol (180.25(e)) and polydextrose (172.841). Searches for yacon, fructooligosaccharide(s) and oligofructose return 0 results, and FDA's GRN 1271 scFOS letter raises only claims. This is an absence in the texts opened, not a ruling that none is needed. The EUR-Lex consolidated text could not be opened. |
No sourced figure in our records. A dash is not a zero, and we do not estimate one.
The label column says when a rule requires a laxative statement on a pack. It is not the amount a person tolerates: the tolerance column is the measured evidence, and the two can be far apart.
"None found" means none in the texts we opened, not a ruling that none is needed.
Tolerance is printed as our record states it. "Single sitting" and "per day" measure different things and are kept apart; g/kg means grams per kilogram of body weight. This chart does not work out an amount for any person.
Sweeteners with neither a tolerance entry nor a label entry in our records are not listed.
Open "Note" under a figure for the qualifications that go with it. The number in square brackets is its source, listed under the chart.
Declared interest (Maltitol (digestive tolerance)): Maltitol was a gift from Towa Chemical Industry (a maltitol maker); partly funded by a Japanese government Grant-in-Aid.
Declared interest (Inulin (chicory root fibre) (digestive tolerance)): Publication fees paid by the IAFNS Carbohydrate Committee (industry-pooled). "HDH has received grant funding from Danone, Tate & Lyle, General Mills, and speaking honoraria from Beneo and the Calorie Control Council."
Declared interest (Yacon syrup (digestive tolerance)): "This research was supported by CONICET, CIUNT, ANPCyT (Argentina) and International Potato Center (Peru) grants"; co-author Manrique is CIP staff, and CIP made the syrup. Declared: "There are no conflict of interests."
Print or save as PDF: chart 3 of 3, Digestive tolerance and laxative labels
Sources for chart 3
The warnings above the chart carry their own source lines.
- Re-evaluation of erythritol (E 968) as a food additive. EFSA Panel on Food Additives and Flavourings, EFSA Journal 21(12):e8430. regulatory checked 29 Aug 2026
- Regulation (EU) No 1169/2011 on food information to consumers — Annex III. European Parliament and Council (text as adopted, and current GB version, via legislation.gov.uk). regulatory checked 3 Nov 2026
- Gastrointestinal Tolerance of D-Allulose in Healthy and Young Adults. A Non-Randomized Controlled Trial. Han Y et al., Nutrients 10(12):2010. peer reviewed checked 30 Aug 2026
- D-Tagatose (addendum) — WHO Food Additives Series 54, 63rd JECFA. Joint FAO/WHO Expert Committee on Food Additives (INCHEM). regulatory checked 27 Oct 2026
- Commission Implementing Regulation (EU) 2017/2470 — Union list of novel foods, entry "D-Tagatose". European Commission (text as adopted, via legislation.gov.uk). regulatory checked 3 Nov 2026
- Suppressive effect of cellulose on osmotic diarrhea caused by maltitol in healthy female subjects. Oku T, Hongo R, Nakamura S; Journal of Nutritional Science and Vitaminology 54(4):309-314. peer reviewed checked 27 Oct 2026Declared interest: Maltitol was a gift from Towa Chemical Industry (a maltitol maker); partly funded by a Japanese government Grant-in-Aid.
- Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Hyams JS; Gastroenterology 84(1):30-33. peer reviewed checked 27 Oct 2026
- 21 CFR 184.1835 — Sorbitol. Electronic Code of Federal Regulations. regulatory checked 3 Nov 2026
- Gastrointestinal Effects and Tolerance of Nondigestible Carbohydrate Consumption. Mysonhimer AR, Holscher HD; Advances in Nutrition 13(6):2237-2276. peer reviewed checked 27 Oct 2026Declared interest: Publication fees paid by the IAFNS Carbohydrate Committee (industry-pooled). "HDH has received grant funding from Danone, Tate & Lyle, General Mills, and speaking honoraria from Beneo and the Calorie Control Council."
- Yacon syrup: Beneficial effects on obesity and insulin resistance in humans. Genta S, Cabrera W, Habib N, Pons J, Manrique Carillo I, Grau A, Sánchez S; Clinical Nutrition 28(2):182-187. peer reviewed checked 27 Oct 2026Declared interest: "This research was supported by CONICET, CIUNT, ANPCyT (Argentina) and International Potato Center (Peru) grants"; co-author Manrique is CIP staff, and CIP made the syrup. Declared: "There are no conflict of interests."
Sources, the date each was opened, and the qualifications that go with each figure are listed under this chart at zerosugar.ai/tools/printable-charts/. Figures change: check the page before relying on an old printout.
Disclosure: the operator of this site sells erythritol-based products, so we have a commercial interest in some of the sweeteners this tool covers. Every figure links to its source so you can check it. See our terms for how we handle this.
Educational information, not medical or dietary advice. This tool does not know your situation and does not tell you what to eat. If you are managing diabetes, are pregnant, take medication, or have a condition affected by what you eat, talk to a clinician or a registered dietitian before acting on anything it shows.
Educational information, not medical or dietary advice. This tool does not know your situation and does not tell you what to eat. If you are managing diabetes, are pregnant, take medication, or have a condition affected by what you eat, talk to a clinician or a registered dietitian before acting on anything it shows.
These charts are free to print. Leave an email to hear when new tools go live.
This page is educational information, not medical or dietary advice. Nutrition and regulatory details change over time — verify against the cited primary sources before relying on them for formulation or health decisions.